One Stop Shop for All Your Market Research Reports

Global Erythropoietin (EPO) Market Professional Survey Report 2019

Rising incidence of chronic diseases such as CKD and cancer resulting in anemia is a major growth driver of Erythropoietin (EPO) Drugs market. According to the statistics published by the National Heart, Lung, and Blood Institute of the U.S. Department of Health & Human Services, over 3 million people are affected by anemia every year and this number is expected to increase over the forecast period. This showcases the need for erythropoietin-stimulating agents in the coming years. The global Erythropoietin (EPO) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Erythropoietin (EPO) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Erythropoietin (EPO) market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Erythropoietin (EPO) in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Erythropoietin (EPO) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market. The following manufacturers are covered: Amgen Johnson & Johnson Roche Galenica Emcure Kyowa Hakko Kirin 3SBio Biocon LG Life Sciences Segment by Regions North America Europe China Japan Southeast Asia India Segment by Type Epoetin-alfa Darbepoetin-alfa Epoetin-beta Others Segment by Application Anemia Kidney Disorders Other
Table of Contents Executive Summary 1 Industry Overview of Erythropoietin (EPO) 1.1 Definition of Erythropoietin (EPO) 1.2 Erythropoietin (EPO) Segment by Type 1.2.1 Global Erythropoietin (EPO) Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Epoetin-alfa 1.2.3 Darbepoetin-alfa 1.2.4 Epoetin-beta 1.2.5 Others 1.3 Erythropo
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3500
Multi User US $5250
Corporate User US $7000
About this Report
Report ID 426255
  • Pharmaceuticals and Healthcare
Published on 30-Dec
Number of Pages 108
Publisher Name QY Research
Editor Rating